Usability of a pre-filled insulin injection device in a 3-month observational survey of everyday clinical practice in Australia

Current Medical Research and Opinion

Volumn 24, Issue 10, 2008, Pages 2741-2749

  Carter, John ^a   Roberts, Anthony ^b  

^a Department of Microbiology and Infectious Diseases   (Australia)

^b South Australian Endocrine Clinical Research   (Australia)

Author keywords

Acceptability; Diabetes mellitus; Injection device; Insulin; Observational survey; SoloSTAR; Usability

Indexed keywords

INSULIN GLARGINE;

ADULT; ARTICLE; AUSTRALIA; CLINICAL PRACTICE; CONTROLLED STUDY; FEMALE; HUMAN; INJECTION PISTOL; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; OPEN STUDY; PATIENT ATTITUDE; PATIENT EDUCATION; PHYSICIAN ATTITUDE; SELF CARE;

ADULT; AGED; AUSTRALIA; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EQUIPMENT DESIGN; EQUIPMENT SAFETY; FEMALE; HEALTH EDUCATORS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PHYSICIANS; SYRINGES;

EID: 55549141537     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/03007990802367579     Document Type: Article

References (22)

1. Bohannon NJ. Insulin delivery using pen devices. Simple-to-use tools may help young and old alike. Postgrad Med 1999;106: 57-8, 61-4, 8
2. Graff MR, McClanahan MA. Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe. Clin Ther 1998;20:486-96
3. Klonoff DC. The pen is mightier than the needle (and syringe). Diabetes Technol Ther 2001;3:631-3
4. Summers KH, Szeinbach SL, Lenox SM. Preference for insulin delivery systems among current insulin users and nonusers. Clin Ther 2004;26:1498-505
5. Clarke A, Dain MP. Dose accuracy of a reusable insulin pen using a cartridge system with an integrated plunger mechanism. Expert Opin Drug Deliv 2006;3:677-83
6. Clarke A, Spollett G. Dose accuracy and injection force dynamics of a novel disposable insulin pen. Expert Opin Drug Deliv 2007;4:165-74
7. Robertson KE, Glazer NB, Campbell RK. The latest developments in insulin injection devices. Diabetes Educ 2000;26: 135-8, 41-6, 49-52
8. Whiteside MM, Wallhagen MI, Pettengill E. Sensory impairment in older adults: part 2: Vision loss. Am J Nurs 2006; 106:52-61,quiz-2
9. Gehrs KM, Anderson DH, Johnson LV, et al. Age-related macular degeneration - emerging pathogenetic and therapeutic concepts. Ann Med 2006;38:450-71
10. Wong TY, Klein R, Amirul Islam FM, et al. Three-year incidence and cumulative prevalence of retinopathy: the atherosclerosis risk in communities study. Am J Ophthalmol 2007; 143:970-6
11. Ziegler D, Gries FA, Spuler M, et al. The epidemiology of diabetic neuropathy. DiaCAN Multicenter Study Group. Diabet Med 1993;10(Suppl 2):82S-86S
12. Starkman HS, Gleason RE, Rand LI, et al. Limited joint mobility (LJM) of the hand in patients with diabetes mellitus: relation to chronic complications. Ann Rheum Dis 1986;45:130-5
13. Haak T, Edelman SV, Walter C, et al. Comparison of the usability and patient preference for the new disposable insulin device SoloStar versus FlexPen, Lilly Disposable pen, and a prototype pen: an open-label study. Clin Ther 2007;29:650-60
14. Asakura T, Seino H, Kageyama M, et al. Dosing accuracy of two insulin pre-filled pens. Curr Med Res Opin 2008;24:1429-34
15. Hanel H, Weise A, Sun W, et al. Differences in the dose accuracy of insulin pens. J Diabetes Sci Technology 2008;2:478-81
16. Hermanns N, Kulzer B, Krichbaum M, et al. Hohe Dosiergenauigkeit des LANTUS® SoloStar® und des APIDRA® SoloStar® Insulinfertigpens [High dose accuracy of LANTUS® SoloStar® and APIDRA® SoloStar® disposable insulin pens] Diabetologie Stoffwechsel 2008;3:S97 [Abstract 286]
17. Schwartz SL, Vlajnic A. Validation of the SoloStar insulin pen J Diabetes Sci Technology 2007;1:A159
18. Carter J, Beillin J, Morton A, et al. Usability, participant acceptance and safety of SoloStar in a 3-month observational survey in everyday clinical practice. J Diabetes Sci Technology 2007; 1:A21
19. Peyrot M, Rubin RR, Lauritzen T, et al. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care 2005;28:2673-9
20. Polonsky WH, Fisher L, Guzman S, et al. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care 2005;28:2543-5
21. Cull WL, O'Connor KG, Sharp S, et al. Response rates and response bias for 50 surveys of pediatricians. Health Serv Res 2005;40:213-26
22. McFarlane E, Olmsted MG, Murphy J, et al. Nonresponse bias in a mail survey of physicians. Eval Health Prof 2007;30: 170-85